VivoSim Labs, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
VivoSim Labs, Inc. (VIVS) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $44.30 million as of 2025-03-31, per its 10-K filed 2025-06-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2025-06-05
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $44.30M.
- 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $42.80M.
- 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $40.90M.
- 2022-03-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $40.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2025-03-31 | $44.30M 10-K · filed 2025-06-05 |
| 2024-03-31 | $42.80M 10-K · filed 2024-05-31 |
| 2023-03-31 | $40.90M 10-K · filed 2023-07-14 |
| 2022-03-31 | $40.50M 10-K · filed 2022-06-10 |
| 2021-03-31 | $40.40M 10-K · filed 2021-06-15 |
| 2020-03-31 | $33.40M 10-K · filed 2020-05-28 |
| 2019-03-31 | $49.20M 10-K · filed 2019-06-03 |
| 2018-03-31 | $78.03M 10-K · filed 2018-05-31 |
| 2017-03-31 | $69.04M 10-K · filed 2017-06-07 |
| 2016-03-31 | $89.06M 10-K · filed 2016-06-09 |
| 2015-03-31 | $58.85M 10-K · filed 2015-06-09 |
| 2014-03-31 | $34.83M 10-K · filed 2014-06-10 |
| 2013-03-31 | $15.38M 10-KT · filed 2013-05-24 |
| 2012-12-31 | $11.86M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |